Fracture risk with intermittent high-dose oral glucocorticoid therapy.

Fracture risk with intermittent high-dose oral glucocorticoid therapy.

OBJECTIVE: To evaluate the risk of fracture in patients receiving intermittent therapy with high-dose oral glucocorticoids (GCs). METHODS: The study group comprised 191,752 patients from the UK General Practice Database who were 40 years of age and older and received therapy with GCs. The followup t...

Detaylı Bibliyografya
Asıl Yazarlar:	De Vries, F, Bracke, M, Leufkens, H, Lammers, J, Cooper, C, Van Staa, T
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2007

Benzer Materyaller

Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case-control study.
Yazar:: de Vries, F, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

CUMULATIVE RISKS OF FRACTURE IN PATIENTS USING ORAL GLUCOCORTICOIDS
Yazar:: Van Staa, T, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Severity of obstructive airway disease and risk of osteoporotic fracture.
Yazar:: de Vries, F, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Disease severity of asthma/copd and risk of osteoporotic fractures
Yazar:: de Vries, F, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Use of beta-2 agonists and risk of hip fracture
Yazar:: De Vries, F, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Individual fracture risk and the cost-effectiveness of bisphosphonates in patients using oral glucocorticoids.
Yazar:: van Staa, T, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Use of beta-2 agonists and risk of hip/femur fracture: a population-based case-control study.
Yazar:: de Vries, F, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Risk of incident fracture is associated with dose, duration and recency of oral glucocorticoid exposure
Yazar:: Robinson, DE, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Oral corticosteroids and fracture risk: relationship to daily and cumulative doses.
Yazar:: van Staa, T, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids.
Yazar:: van Staa, T, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Use of beta-blockers and risk of hip and vertebral fracture: relationships to daily and cumulative dose
Yazar:: De Vries, F, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Children and the risk of fractures caused by oral corticosteroids.
Yazar:: van Staa, T, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Bone loss and inhaled glucocorticoids.
Yazar:: van Staa, T, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Use of oral corticosteroids and risk of fractures.
Yazar:: Van Staa, T, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Use of statins and risk of fractures.
Yazar:: van Staa, T, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Use of statins and risk of fractures.
Yazar:: van Staa, T, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Statins and fracture risk - Reply
Yazar:: van Staa, T, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

PREDICTORS FOR VERTEBRAL FRACTURES AND FRACTURE THRESHOLD IN PATIENTS USING ORAL GLUCOCORTICOIDS
Yazar:: van Staa, T, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Use of oral corticosteroids and risk of fractures. June, 2000.
Yazar:: Van Staa, T, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy.
Yazar:: Van Staa, T, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Inhaled corticosteroids and risk of fractures
Yazar:: Van Staa, T, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Use of statins, risk of fracture and age-band bias
Yazar:: De Vries, F, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Is persistence to bisphosphonate therapy related only to dosing regimen?
Yazar:: van Staa, T, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Use of inhaled corticosteroids and risk of fractures.
Yazar:: van Staa, T, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Use of nonsteroidal anti-inflammatory drugs and risk of fractures.
Yazar:: van Staa, T, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Use of beta-blockers and the risk of hip/femur fracture in the United Kingdom and The Netherlands.
Yazar:: de Vries, F, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

The limitations of using simple definitions of glucocorticoid exposure on the prediction of fracture risk
Yazar:: Robinson, D, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Utility of medical and drug history in fracture risk prediction among men and women.
Yazar:: van Staa, T, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Reanalysis of two studies with contrasting results on the association between statin use and fracture risk: the General Practice Research Database.
Yazar:: de Vries, F, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Reanalysis of two studies with contrasting results on the association between statin use and fracture risk: the General Practice Research Database
Yazar:: de Vries, F, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

The value of bone turnover markers in the prediction of vertebral fracture in patients using oral glucocorticoids.
Yazar:: van Staa, T, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

A reanalysis of two studies that reported contrasting results on the association between statin use and risk of fracture in the same data source
Yazar:: de Vries, F, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results.
Yazar:: Van Staa, T, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Use of oral corticosteroids and risk of fractures (reprinted from JBMR, vol. 15, pg. 993-1000, yr. 2000)
Yazar:: Van Staa, T, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Antipsychotic use and the risk of hip/femur fracture: a population-based case-control study.
Yazar:: Pouwels, S, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Are inhaled corticosteroids associated with an increased risk of fracture in children?
Yazar:: van Staa, T, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Risk of fracture in patients with Guillain-Barre syndrome.
Yazar:: Pouwels, S, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Use of protonpump inhibitors and risk of hip fracture
Yazar:: Lalmohamed, A, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Use of Protonpump Inhibitors and Risk of Hip Fracture
Yazar:: Lalmohamed, A, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

The use of inhaled corticosteroids is not associated with an increased risk of fracture in children.
Yazar:: van Staa, T, ve diğerleri
Baskı/Yayın Bilgisi: (2001)